Condition
EUS-FNA
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Unknown2
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03085004Phase 3Terminated
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts
NCT04939103CompletedPrimary
TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer
NCT04707560Not ApplicableUnknown
Heparin-based Wet Suction Method in EUS Fine Needle Biopsy of Solid Pancreatic Mass
NCT01923883Not ApplicableUnknownPrimary
Comparison of EUS-Guided Fine Needle Aspiration Technique
Showing all 4 trials